Stock KNSA KINIKSA PHARMACEUTICALS, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Kiniksa Pharmaceuticals, Ltd.

Equities

KNSA

BMG5269C1010

Real-time Estimate Cboe BZX
Other stock markets
 11:22:25 2024-04-30 am EDT 		5-day change 1st Jan Change
18.72 USD +0.89% Intraday chart for Kiniksa Pharmaceuticals, Ltd. +5.43% +6.27%
Apr. 23 Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises MT
Apr. 23 Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Insider Sell: Kiniksa Pharmaceuticals
MT
Insider Sell: Kiniksa Pharmaceuticals
MT
Insider Sell: Kiniksa Pharmaceuticals
MT
Kiniksa Pharmaceuticals, Ltd. Appoints Eben Tessari as SVP, Chief Operating Officer and Principal Operating Officer
CI
Kiniksa Pharmaceuticals : Announces Launch of ARCALYST Named Patient Program
AQ
Kiniksa Pharmaceuticals, Ltd. Announces Launch of ARCALYST Named Patient Program
CI
Kiniksa Pharmaceuticals, Ltd. Announces Management Changes
CI
Kiniksa Pharmaceuticals, Ltd. Announces Management Changes
CI
Kiniksa Pharmaceuticals, Ltd. Announces Executive Changes
CI
Kiniksa Pharmaceuticals, Ltd. Announces Executive Changes
CI
Kiniksa Pharmaceuticals, Ltd. Announces Executive Changes
CI
Kiniksa Pharmaceuticals, Ltd. Appoints Richard S. Levy to Board
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KNSA Stock
  4. News Kiniksa Pharmaceuticals, Ltd.
  5. Insiders